These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36288863)

  • 1. A Survival Score for Very Elderly Patients With Brain Metastases Assigned to Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Rades D; Delikanli C; Blanck O; Schild SE; Janssen S
    Anticancer Res; 2022 Nov; 42(11):5629-5634. PubMed ID: 36288863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival After Stereotactic Radiosurgery (SRS) or Fractionated Stereotactic Radiotherapy (FSRT) for Cerebral Metastases in the Elderly.
    Rades D; Nguyen T; Blanck O; Schild SE
    In Vivo; 2020; 34(4):1909-1913. PubMed ID: 32606162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the Risk of Subsequent Distant Brain Metastases After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy in Elderly Patients.
    Rades D; Nguyen T; Dziggel L; Blanck O; Schild SE
    Anticancer Res; 2020 Jul; 40(7):4081-4086. PubMed ID: 32620656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Score to Identify Patients with Brain Metastases from Colorectal Cancer Who May Benefit from Whole-brain Radiotherapy in Addition to Stereotactic Radiosurgery/Radiotherapy.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):3111-3114. PubMed ID: 29715148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Survival Score for Patients Receiving Stereotactic Radiosurgery Alone for Brain Metastases from Breast Cancer.
    Rades D; Dziggel L; Janssen S; Blanck O; Hornung D; Schild SE
    Anticancer Res; 2016 Mar; 36(3):1073-6. PubMed ID: 26977000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of a Survival Score for Patients Receiving Radiosurgery or Fractionated Stereotactic Radiotherapy for 1 to 3 Brain Metastases.
    Rades D; Blanck O; Khoa MT; VAN Thai P; Hung NQ; Dziggel L; Schild SE
    In Vivo; 2018; 32(2):381-384. PubMed ID: 29475924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A New Predictive Tool for Optimization of the Treatment of Brain Metastases from Colorectal Cancer After Stereotactic Radiosurgery.
    Rades D; Dahlke M; Gebauer N; Bartscht T; Hornung D; Trang NT; Phuong PC; Khoa MT; Gliemroth J
    Anticancer Res; 2015 Oct; 35(10):5515-8. PubMed ID: 26408718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic grading system specifically for elderly patients with brain metastases after stereotactic radiosurgery: a 2-institution study.
    Yamamoto M; Serizawa T; Higuchi Y; Nagano O; Aiyama H; Koiso T; Watanabe S; Kawabe T; Sato Y; Kasuya H
    J Neurosurg; 2018 Dec; 129(Suppl1):95-102. PubMed ID: 30544299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frameless stereotactic radiosurgery for brain metastases: a review of outcomes and prognostic scores evaluation.
    Mok ST; Kam MK; Tsang WK; Poon DM; Loong HH; Yeung WM; Yeung TY; Yu J; Wong CK
    Hong Kong Med J; 2017 Dec; 23(6):599-608. PubMed ID: 29125123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
    Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
    J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic radiosurgery for brain metastases from pelvic gynecological malignancies: oncologic outcomes, validation of prognostic scores, and dosimetric evaluation.
    Meixner E; Eichkorn T; Erdem S; König L; Lang K; Lischalk JW; Michel LL; Schneeweiss A; Smetanay K; Debus J; Hörner-Rieber J
    Int J Gynecol Cancer; 2022 Feb; 32(2):172-180. PubMed ID: 34848530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
    Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
    J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
    Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Werner-Wasik M; Demas W; Ryu J; Bahary JP; Souhami L; Rotman M; Mehta MP; Curran WJ
    Lancet; 2004 May; 363(9422):1665-72. PubMed ID: 15158627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosurgery for brain metastases: a score index for predicting prognosis.
    Weltman E; Salvajoli JV; Brandt RA; de Morais Hanriot R; Prisco FE; Cruz JC; de Oliveira Borges SR; Wajsbrot DB
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1155-61. PubMed ID: 10725626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma.
    Hauswald H; Stenke A; Debus J; Combs SE
    BMC Cancer; 2015 Jul; 15():537. PubMed ID: 26201853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.